TMC Completes Successful CTIS Submission
TMC is delighted to announce a successful, validated clinical trial submission using the new EU Clinical Trial Information System (CTIS) on behalf of one of our clients. TMC is a global pharma development organisation with full product development lifecycle expertise from pre-clinical through to post-marketing, focused on developing tailored solutions for biopharmaceutical companies. Our experience …